Future of Family Planning (Horizontal Thesis)

Concept

New clinical models, digital health models, and biology for tackling family planning will enable multiple venture scale businesses to emerge.

Longer Description

More novel care models, advanced technology, and advancements in biotech have meant that we have better tools to align societal shifts with biology in order to allow more freedom and opportunity in the family planning process.

We began investing against this thesis with Tia, a women’s healthcare company, as we saw that women weren’t often building lasting relationships with their doctors until childbirth and that a new care model could provide better outcomes.

We have since made multiple investments in the space from digital health through biotech. We believe there are likely other investments to be made still in areas related to female fertility, male fertility, as well as adjacently menopause, among others.

Investments include:

• Tia
• We co-led Tia’s seed round and have seen the company materially scale over the past few years. The core learnings for Tia have been that impacting outcomes often requires a more hands-on or clinical approach, as well as that novel care models are what create venture outcomes for businesses in the arena. We believe Tia is one of the most important companies in women’s health broadly (we are aware women’s health ≠ family planning entirely).